Cargando…

How important are COVID-19 vaccine responses in patients with MS on disease-modifying therapies?

Detalles Bibliográficos
Autor principal:	Giovannoni, Gavin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996445/ https://www.ncbi.nlm.nih.gov/pubmed/35487035 http://dx.doi.org/10.1016/j.msard.2022.103803

Ejemplares similares

The COVID-19 pandemic and the use of MS disease-modifying therapies
por: Giovannoni, Gavin, et al.
Publicado: (2020)

COVID-19 vaccines and multiple sclerosis disease-modifying therapies
por: Giovannoni, Gavin, et al.
Publicado: (2021)

Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19
por: Giovannoni, Gavin
Publicado: (2020)

COVID-19 vaccines and vaccination: how prepared is Africa?
por: Ariyo, Olumuyiwa Elijah, et al.
Publicado: (2021)

Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes
por: Holroyd, Kathryn B., et al.
Publicado: (2022)

COVID-19 and MS disease-modifying therapies
por: Berger, Joseph R., et al.
Publicado: (2020)

Cognition and its relation to brain health in patients with MS: Response to letter
por: Hobart, Jeremy, et al.
Publicado: (2020)

How important is gametocyte clearance after malaria therapy?
por: Karunajeewa, Harin A., et al.
Publicado: (2016)

Effects of MS disease-modifying therapies on responses to vaccinations: A review.
por: Ciotti, John Robert, et al.
Publicado: (2020)

How health workers can make a difference in the public COVID-19 vaccination response
por: Habersaat, Katrine B., et al.
Publicado: (2022)

The importance of seasonal influenza vaccination for people with disabilities during the COVID-19 pandemic
por: Peacock, Georgina, et al.
Publicado: (2021)

The importance of addressing social inequalities and targeting the undecided to promote vaccination against COVID-19
por: Rozbroj, Tomas, et al.
Publicado: (2021)

COVID-19 containment: China provides important lessons for global response
por: Zhang, Shuxian, et al.
Publicado: (2020)

The development of COVID-19 vaccines in the United States: Why and how so fast?
por: Kuter, Barbara J., et al.
Publicado: (2021)

The COVID-19 Response in Nebraska: How Students Answered the Call
por: Chengane, Sabrine, et al.
Publicado: (2020)

An Important but Overlooked Measure for Containing the COVID-19 Epidemic: Protecting Patients with Chronic Diseases
por: Wu, Jing
Publicado: (2020)

We Should Do More to Offer Evidence-Based Treatment for an Important Modifiable Risk Factor for COVID-19: Obesity
por: Dutta, Nirjhar, et al.
Publicado: (2021)

The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients
por: Kloc, Malgorzata, et al.
Publicado: (2020)

How to ensure we can track and trace global use of COVID-19 vaccines?
por: Vander Stichele, Robert H., et al.
Publicado: (2021)

Rapid evaluation of the safety of COVID-19 vaccines: how well have we done?
por: Miller, Elizabeth
Publicado: (2022)

How Can We Best Use COVID-19 Vaccines in Adolescents? An International Perspective
por: Zhong, Youjia, et al.
Publicado: (2021)

Patient Power Revolution in Multiple Sclerosis: Navigating the New Frontier
por: Yeandle, David, et al.
Publicado: (2018)

Pharmacists as important prescribers of coronavirus disease 2019 (COVID-19) antivirals
por: Mahoney, Monica V., et al.
Publicado: (2022)

Immunological response after mild COVID-19: How long will it last?
por: Balduzzi, Adriana
Publicado: (2021)

Response to “How prepared is Africa to face COVID-19?” by Wadoum and Clarke
por: Awoonor-Williams, John Koku, et al.
Publicado: (2020)

The importance of community engagement on COVID-19 vaccination strategy: Lessons from two California pilot programs
por: Mondal, Agastya
Publicado: (2021)

Risk of COVID-19 infection and severe disease in MS patients on different disease-modifying therapies
por: Smith, Tyler E, et al.
Publicado: (2022)

How to ensure a needs-driven and community-centred vaccination strategy for COVID-19 in Africa
por: Boum II, Yap, et al.
Publicado: (2021)

COVID-19 variants as moving targets and how to stop them by glycoengineered whole-virus vaccines
por: Galili, Uri
Publicado: (2021)

An Evaluation of Local Pharmaceutical Manufacturing in Zimbabwe: How Prepared is Zimbabwe to Produce COVID-19 Vaccines?
por: Okereke, Melody, et al.
Publicado: (2022)

Recognizing the Importance of Vaccine Confidence
por: Black, Steven
Publicado: (2016)

Vaccines are not yet a silver bullet: The imperative of continued communication about the importance of COVID-19 safety measures
por: Su, Zhaohui, et al.
Publicado: (2021)

Commentary: The importance of operative timing in the era of coronavirus disease 2019 (COVID-19)
por: Costello, John P., et al.
Publicado: (2021)

B cell therapy and the use of RNA-based COVID-19 vaccines
por: Vishnevetsky, Anastasia, et al.
Publicado: (2021)

The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic
por: Baker, David, et al.
Publicado: (2020)

Smoke evacuation, is it important for prevention of COVID‐19?
por: Zhaori, Getu
Publicado: (2020)

The Importance of Video Visits in the Time of COVID‐19
por: Lindsay, Jan A., et al.
Publicado: (2020)

Knowledge regarding COVID-19 pandemic in patients with multiple sclerosis (MS): A report from Iran
por: Sahraian, Mohammad Ali, et al.
Publicado: (2020)

How important is randomisation in a stepped wedge trial?
por: Hargreaves, James R, et al.
Publicado: (2015)

Pulmonary arterial thrombosis as an important complication of COVID-19 pulmonary disease: letter to the editor
por: Lax, Sigurd F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b8stqcdfsso1tsfqq554go5pf4